IL7 and neoplasm: Moreover, Toyota et al. combined the conjugation of the OVA model antigen on the surface of PEG-PGA-based nanoparticles with the inclusion of interleukin-7 inside them to generate antigen-specific antitumor immune responses with tumor regression in E.G7-OVA tumor-bearing mice.